Follicular Lymphoma Grade 3b
📧 Sign up to get email alerts when something new happens for Follicular Lymphoma Grade 3b.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Autologous CD22 CAR T Cells in Adults w/ Recurrent or Refractory B Cell Malignancies [Phase 1]
Phase 1 trial evaluating autologous CD22 CAR T cells in adults with recurrent or refractory B-cell malignancies has completed enrollment. Re…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: Acalabrutinib + Liso-Cel In R/R Aggressive B-Cell Lymphomas [Phase 2]
Phase 2 study evaluating acalabrutinib plus lisocabtagene maraleucel (Liso-Cel) in refractory/relapsed aggressive B-cell lymphomas, includin…
-
CLINICAL_TRIALS trial_result · 2025-09-29Clinical Trial Update: Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) [Phase 2]
Phase 2 clinical trial assessing the combination of loncastuximab tesirine and epcoritamab in relapsed/refractory aggressive B-cell lymphoma…
-
CLINICAL_TRIALS trial_result · 2019-05-17Clinical Trial Update: Treatment Study of Denintuzumab Mafodotin (SGN-CD19A) Plus RICE Versus RICE Alone for Diffuse Large B-Cell Lymphoma [Phase 2]
Phase 2 trial comparing denintuzumab mafodotin plus RICE versus RICE alone in diffuse large B-cell lymphoma; the study is terminated with re…
-
CLINICAL_TRIALS trial_result · 2016-05-26Clinical Trial Update: A Multicentre, Randomized Phase III Study of Rituximab as Maintenance Treatment Versus Observation in Patients With Aggressive B-cell Lymphoma: NHL-13 [Phase 3]
This update reports the completion of a multicentre, randomized Phase III trial evaluating rituximab as maintenance therapy versus observati…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.